We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
aylo's goal is to expedite the shift toward a circular economy. With £22 million in annual recurring revenue, backing from venture capital, and certification as a B Corp, their technology platform facilitates the leasing and reusing of consumer products, making sustainability more accessible and affordable. Raylo recognizes that consumers and retailers will embrace this transition if it's both cost-effective and straightforward.
days to go: Expired investment: £1,282,150
With new MiFID II regulations introduced in January, Hiddensee provides independent investment research mainly on forensic accounting and corporate governance. Analysts will search for inconsistencies and anomalies in the valuation of UK listed mid-cap and smaller companies and publish their reports to assist investors in deciding whether to buy or sell shares.
days to go: Expired investment: £143,097
Yielders is a real-estate investment platform that minimises the barriers of entering a traditionally inaccessible asset class. This award-winning platform is the UK’s first finance FinTech company which is regulated by FCA. The company had received authorization from FCA in 2017. Yielders received 2017 Islamic Economy Award and became finalist twice for the EFICA Innovative Finance award. It also received IFN's global award for the Best Islamic Crowdfunding Platform category. The company has over 2500 on-boarded investors. The company has achieved and completed more than £6m AUM. Yielders aims to deliver steady returns for a conscientious modern investor. Yielders plans to utilise the proceeds for product development, technology, talent acquisition, and building its presence around GCC, the UK and the global Islamic Market.
days to go: Expired investment: £686,178
JustUs plans to offer its own ISA's directly to consumers via IFA's and by doing so they are disrupting the £1.5 trillion lending and savings market in the UK. 
days to go: Expired investment: £12,580
Knoma is a payment solution that helps people looking to future-proof their career or move into new areas of work by eliminating the burden of upfront payment, and by removing the challenges of sourcing an appropriate course. Backed by a large European Venture Capital firm, Knoma enables lifelong learning as the global economy transitions to one where digital skills are essential for career success. All Knoma students can gain access up to £10,000 to pay for the course of their choice, which can be spread over 12 months with flexible repayments with no interest or fees applicable. The company has partnered with organisations like Codeclan, Wild Code School, Le Wagon, and Code Nation and has successfully secured £750,000 in funding from some of Europe's largest venture capital firms, namely, Global Founders Capital, and Rocket Internet. The company will utilise the investments to expand partnerships with tech and coding schools, test and deploy the Knoma app, unlock a £20 million debt facility to provide Knoma loans to its students, and scale the business on all verticals.
days to go: Expired investment: £529,660
epaysecure is a secure payment system, which offers comprehensive payment and benefit options, and allows all the services the consumer demands to be offered in one card and e-account. The prepaid business purchasing in European markets is estimated to be $700 million. The company operates in an e-banking and financial services marketing sector that helps clients by identifying new markets and bringing in new ideas to develop them through reloadable products and e-Wallet platform. The funds will be used for staffing, set up costs, other overheads including property marketing and general office costs.

Pitch Rated

73%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £168,340
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph